EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan and currently employs 297 full-time employees. The company went IPO on 2002-06-05. The firm develops and produces in-vitro diagnostic (IVD) devices and tests designed for use at or near the patient’s location. The company provides a suite of products for diabetes management, including glucose monitoring systems and associated consumables. The company offers devices, supplies, and consumables for measuring hemoglobin levels, including tools for detecting hemoglobin variants. The company also develops and supplies diagnostic and therapeutic enzymes, proteins, reagents, and biomaterials. The company provides precision fermentation, custom bioprocessing, and contract manufacturing services for pharmaceuticals and other biological products. The company supplies beta-hydroxybutyrate (HB) products used in ketone detection to support the diagnosis of diabetic ketoacidosis and other clinical conditions.
EKF Diagnostics Holdings PLC Información sobre dividendos
EKF Diagnostics Holdings PLC tiene un dividendo anual de 0.00 por acción, con un rendimiento del 0.00%. El dividendo se paga anualmente y la última fecha ex-dividendo fue Nov 2, 2023.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
0.00%
$0.00
Nov 2, 2023
Frecuencia de pago
Relación de pago
Anualmente
0.00%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Nov 2, 2023
$0.012
Nov 3, 2023
Dec 1, 2023
Nov 3, 2022
$0.012
Nov 4, 2022
Dec 1, 2022
Nov 4, 2021
$0.011
Nov 5, 2021
Dec 1, 2021
Nov 5, 2020
$0.01
Nov 6, 2020
Dec 1, 2020
Gráficos de dividendos
EKDHF Dividendos
EKDHF Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por EKF Diagnostics Holdings PLC y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de EKF Diagnostics Holdings PLC?